Spam gets the sniffles

Posted by Virus Bulletin on Oct 28, 2004

Spammers seize the opportunity to cash in on the US flu vaccine problem.

Not only has the shortage of flu vaccine been something of a political hot potato in the run up to the US Presidential elections, but now spammers have seized the opportunity to cash in on the problem. Canadian email security firm Vircom says it has seen a surge of emails touting flu vaccinations, generally at highly inflated prices. It looks like Viagra may have to take a back seat until the flu season has passed.

Posted on 28 October 2004 by Virus Bulletin

Latest posts:

VBSpam tests to be executed under the AMTSO framework

VB is excited to announce that, starting from the Q3 test, all VBSpam tests of email security products will be executed under the AMTSO framework.

In memoriam: Prof. Ross Anderson

We were very sorry to learn of the passing of Professor Ross Anderson a few days ago.

In memoriam: Dr Alan Solomon

We were very sorry to learn of the passing of industry pioneer Dr Alan Solomon earlier this week.

New paper: Nexus Android banking botnet – compromising C&C panels and dissecting mobile AppInjects

In a new paper, researchers Aditya K Sood and Rohit Bansal provide details of a security vulnerability in the Nexus Android botnet C&C panel that was exploited in order to gather threat intelligence, and present a model of mobile AppInjects.

New paper: Collector-stealer: a Russian origin credential and information extractor

In a new paper, F5 researchers Aditya K Sood and Rohit Chaturvedi present a 360 analysis of Collector-stealer, a Russian-origin credential and information extractor.